These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 23045027

  • 1. Measurement of cGMP and soluble guanylyl cyclase activity.
    Southam E.
    Curr Protoc Toxicol; 2001 May; Chapter 10():Unit 10.5. PubMed ID: 23045027
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
    Dupont LL, Glynos C, Bracke KR, Brouckaert P, Brusselle GG.
    Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
    [Abstract] [Full Text] [Related]

  • 4. Endurance training upregulates the nitric oxide/soluble guanylyl cyclase/cyclic guanosine 3',5'-monophosphate pathway in the striatum, midbrain and cerebellum of male rats.
    Chalimoniuk M, Chrapusta SJ, Lukačova N, Langfort J.
    Brain Res; 2015 Aug 27; 1618():29-40. PubMed ID: 26006108
    [Abstract] [Full Text] [Related]

  • 5. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
    Reyna-Neyra A, Sarkar G, Etgen AM.
    J Neuroendocrinol; 2007 Jun 27; 19(6):418-25. PubMed ID: 17388815
    [Abstract] [Full Text] [Related]

  • 6. An enzyme-linked receptor mechanism for nitric oxide-activated guanylyl cyclase.
    Roy B, Halvey EJ, Garthwaite J.
    J Biol Chem; 2008 Jul 04; 283(27):18841-51. PubMed ID: 18463095
    [Abstract] [Full Text] [Related]

  • 7. Cyclic GMP synthesis by human retinal pigment epithelial cells is mainly mediated via the particulate guanylyl cyclase pathway.
    Diederen RM, La Heij EC, Markerink-van Ittersum M, Kijlstra A, Hendrikse F, de Vente J.
    Ophthalmic Res; 2007 Jul 04; 39(1):55-9. PubMed ID: 17179739
    [Abstract] [Full Text] [Related]

  • 8. Handbook of Experimental Pharmacology 191. cGMP: generators, effectors and therapeutic implications. Preface.
    Schmidt HH, Hofmann F, Stasch JP.
    Handb Exp Pharmacol; 2009 Jul 04; (191):v-vi. PubMed ID: 19192509
    [No Abstract] [Full Text] [Related]

  • 9. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
    Bellingham M, Evans TJ.
    Cell Signal; 2007 Oct 04; 19(10):2183-93. PubMed ID: 17643962
    [Abstract] [Full Text] [Related]

  • 10. A VASP-Rac-soluble guanylyl cyclase pathway controls cGMP production in adipocytes.
    Jennissen K, Siegel F, Liebig-Gonglach M, Hermann MR, Kipschull S, van Dooren S, Kunz WS, Fässler R, Pfeifer A.
    Sci Signal; 2012 Aug 28; 5(239):ra62. PubMed ID: 22932701
    [Abstract] [Full Text] [Related]

  • 11. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
    Severina IS.
    Biomed Khim; 2007 Aug 28; 53(4):385-99. PubMed ID: 18035720
    [Abstract] [Full Text] [Related]

  • 12. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS, Andric SA, Stojilkovic SS.
    Mol Endocrinol; 2004 Feb 28; 18(2):458-70. PubMed ID: 14630997
    [Abstract] [Full Text] [Related]

  • 13. Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1.
    Beste KY, Burhenne H, Kaever V, Stasch JP, Seifert R.
    Biochemistry; 2012 Jan 10; 51(1):194-204. PubMed ID: 22122229
    [Abstract] [Full Text] [Related]

  • 14. The hepatic soluble guanylyl cyclase-cyclic guanosine monophosphate pathway mediates the protection of remote ischemic preconditioning on the microcirculation in liver ischemia-reperfusion injury.
    Abu-Amara M, Yang SY, Quaglia A, Rowley P, Tapuria N, Fuller B, Davidson B, Seifalian A.
    Transplantation; 2012 May 15; 93(9):880-6. PubMed ID: 22456530
    [Abstract] [Full Text] [Related]

  • 15. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H, Wang Y, Loof T, Martini S, Kron S, Krämer S, Neumayer HH.
    Kidney Int; 2004 Dec 15; 66(6):2224-36. PubMed ID: 15569311
    [Abstract] [Full Text] [Related]

  • 16. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
    Hwang TL, Hung HW, Kao SH, Teng CM, Wu CC, Cheng SJ.
    Mol Pharmacol; 2003 Dec 15; 64(6):1419-27. PubMed ID: 14645672
    [Abstract] [Full Text] [Related]

  • 17. High yield purification of soluble guanylate cyclase from bovine lung.
    Mathis KJ, Emmons TL, Curran DF, Day JE, Tomasselli AG.
    Protein Expr Purif; 2008 Jul 15; 60(1):58-63. PubMed ID: 18430586
    [Abstract] [Full Text] [Related]

  • 18. Modulation of soluble guanylate cyclase activity by phosphorylation.
    Murthy KS.
    Neurochem Int; 2004 Nov 15; 45(6):845-51. PubMed ID: 15312978
    [Abstract] [Full Text] [Related]

  • 19. [Role of sGC-cGMP pathway in CO-mediated regulation of respiratory rhythm].
    Zhang QL, Yang WX, Zhou H, Sun XC, Shi YJ, Chen Q, Zheng Y.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul 15; 38(4):595-8. PubMed ID: 17718419
    [Abstract] [Full Text] [Related]

  • 20. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
    Lee NP, Cheng CY.
    Endocrinology; 2003 Jul 15; 144(7):3114-29. PubMed ID: 12810568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.